Sandoz, a global leader in affordable medicines, announced a €260 million investment in a new biosimilar drug substance facility in Ljubljana, Slovenia.
More
Researchers at Slovenia's largest hospital have achieved a medical breakthrough by proving that an autoimmune disease can be treated by eliminating its underlying trigger.
More
A newly developed molecule by researchers at the Faculty of Pharmacy in Ljubljana has been shown to improve memory and learning in mice suffering from cognitive disorders.
More
South Korean cosmetic and medical product producer T&L has opened its first European production facility in a commercial zone near Maribor.
More
Slovenian tech firm Cosylab has launched PlanOne, an FDA-cleared particle therapy software system developed in collaboration with the U.S. Mayo Clinic.
More
The fully digitally integrated centre will employ over 200 scientists and will support end-to-end drug substance and drug product development.
More
